SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-275814
Filing Date
2022-11-02
Accepted
2022-11-02 16:02:04
Documents
2
Group Members
BKB G2 INVESTMENTS, LLCBKB GROWTH INVESTMENTS, LLCPAUL B. MANNING REVOCABLE TRUST DATED MAY 10, 2000

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d401424dsc13da.htm SC 13D/A 88804
2 EXHIBIT A d401424dex99a.htm EX-99.A 6006
  Complete submission text file 0001193125-22-275814.txt   96252
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Filed by) CIK: 0001494695 (see all company filings)

Type: SC 13D/A

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91724 | Film No.: 221353915
SIC: 2836 Biological Products, (No Diagnostic Substances)